To ablate or not to ablate? HSCs in the T cell driver's seat
Claudio Anasetti1, James J Mulé
1H. Lee Moffitt Comprehensive Cancer Center, Tampa, Florida 33612, USA.
The Journal of Clinical Investigation
|February 3, 2007
Summary
Inducing lymphopenia before cancer immunotherapy, like T cell transfer, boosts treatment effectiveness. Further research explores optimizing lymphodepletion intensity and stem cell transfer for better antitumor responses.
Area of Science:
- Immunology
- Oncology
- Cancer Immunotherapy
Background:
- Lymphopenia induction via chemotherapy or radiation enhances antitumor efficacy of cell-based immunotherapies.
- Mechanisms underlying this enhancement are under active investigation, with room for improvement.
Discussion:
- Wrzesinski and colleagues' study evaluates increasing lymphodepletion intensity and hematopoietic stem cell (HSC) transfer effects.
- The research focuses on the in vivo function of adoptively transferred CD8(+) T cells.
Key Insights:
- Lymphodepletion intensity significantly impacts the efficacy of adoptive T cell transfer in preclinical cancer models.
- Hematopoietic stem cell transfer can modulate the function of transferred CD8(+) T cells.
Outlook:
- Findings provide a basis for optimizing cell-based immunotherapies for cancer treatment.
- Further studies are needed to translate these preclinical findings into clinical applications for enhanced cancer therapy.
Related Concept Videos
01:40Cell-mediated Immune Responses
65.0K
Overview
65.0K
01:01Regulation of Hematopoietic Stem Cells
3.5K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.5K
01:22T Cell Activation and Clonal Selection
13.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
13.7K
01:27Cytotoxic T Cells-mediated Immune Response
7.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.1K